カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

経口狂犬病ワクチンのグローバル市場2023：改変生ウイルス、組換えワクシニア、組換えアデノウイルスワクチン

■ 英語タイトル：Global Oral Rabies Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR23AG11498）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR23AG11498
■ 発行日：2023年8月
■ 調査対象地域：グローバル
■ 産業分野：医薬品＆ヘルスケア
■ ページ数：78
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[経口狂犬病ワクチンのグローバル市場2023：改変生ウイルス、組換えワクシニア、組換えアデノウイルスワクチン]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

Global Info Research社の最新の調査によると、経口狂犬病ワクチンのグローバル市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
本調査レポートは、世界の経口狂犬病ワクチン市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。

市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。

本資料の主な目的は次のとおりです。
- 世界および主要国の市場機会の規模を決定するため
- 経口狂犬病ワクチンの成長可能性を評価するため
- 各製品および最終用途市場の将来の成長を予測するため
- 市場に影響を与える競争要因を評価するため

経口狂犬病ワクチン市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメント
・改変生ウイルス、組換えワクシニア、組換えアデノウイルスワクチン

用途別セグメント
・政府、民間

主要な市場プレーヤー
・Boehringer Ingelheim(Merial)、Ceva Santé Animale(Artemis Technologies)、Virbac

地域別セグメントは次の地域・国をカバーします。
・北米（アメリカ、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、経口狂犬病ワクチン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な経口狂犬病ワクチンメーカーの企業概要、2019年～2022年までの経口狂犬病ワクチンの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な経口狂犬病ワクチンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別経口狂犬病ワクチンの販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までの経口狂犬病ワクチンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域での経口狂犬病ワクチン市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、および経口狂犬病ワクチンの産業チェーンを掲載しています。
・第14、15章では、経口狂犬病ワクチンの販売チャネル、販売業者、顧客、調査結果について説明します。

・市場概要
– 経口狂犬病ワクチンの概要
– 種類別分析（2018年vs2022年vs2029年）：改変生ウイルス、組換えワクシニア、組換えアデノウイルスワクチン
– 用途別分析（2018年vs2022年vs2029年）：政府、民間
– 世界の経口狂犬病ワクチン市場規模・予測
– 世界の経口狂犬病ワクチン生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Boehringer Ingelheim(Merial)、Ceva Santé Animale(Artemis Technologies)、Virbac
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年：改変生ウイルス、組換えワクシニア、組換えアデノウイルスワクチン
・用途別分析2018年-2029年：政府、民間
・経口狂犬病ワクチンの北米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・経口狂犬病ワクチンのヨーロッパ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・経口狂犬病ワクチンのアジア市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・経口狂犬病ワクチンの南米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・経口狂犬病ワクチンの中東・アフリカ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Product Overview and Scope of Oral Rabies Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Oral Rabies Vaccine Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Modified Live Virus
1.3.3 Recombinant Vaccinia
1.3.4 Recombinant Adenovirus Vaccine
1.4 Market Analysis by Application
1.4.1 Overview: Global Oral Rabies Vaccine Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Government
1.4.3 Commercial
1.5 Global Oral Rabies Vaccine Market Size & Forecast
1.5.1 Global Oral Rabies Vaccine Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Oral Rabies Vaccine Sales Quantity (2018-2029)
1.5.3 Global Oral Rabies Vaccine Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Boehringer Ingelheim(Merial)
2.1.1 Boehringer Ingelheim(Merial) Details
2.1.2 Boehringer Ingelheim(Merial) Major Business
2.1.3 Boehringer Ingelheim(Merial) Oral Rabies Vaccine Product and Services
2.1.4 Boehringer Ingelheim(Merial) Oral Rabies Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Boehringer Ingelheim(Merial) Recent Developments/Updates
2.2 Ceva Santé Animale(Artemis Technologies)
2.2.1 Ceva Santé Animale(Artemis Technologies) Details
2.2.2 Ceva Santé Animale(Artemis Technologies) Major Business
2.2.3 Ceva Santé Animale(Artemis Technologies) Oral Rabies Vaccine Product and Services
2.2.4 Ceva Santé Animale(Artemis Technologies) Oral Rabies Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Ceva Santé Animale(Artemis Technologies) Recent Developments/Updates
2.3 Virbac
2.3.1 Virbac Details
2.3.2 Virbac Major Business
2.3.3 Virbac Oral Rabies Vaccine Product and Services
2.3.4 Virbac Oral Rabies Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Virbac Recent Developments/Updates
3 Competitive Environment: Oral Rabies Vaccine by Manufacturer
3.1 Global Oral Rabies Vaccine Sales Quantity by Manufacturer (2018-2023)
3.2 Global Oral Rabies Vaccine Revenue by Manufacturer (2018-2023)
3.3 Global Oral Rabies Vaccine Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Oral Rabies Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Oral Rabies Vaccine Manufacturer Market Share in 2022
3.4.2 Top 6 Oral Rabies Vaccine Manufacturer Market Share in 2022
3.5 Oral Rabies Vaccine Market: Overall Company Footprint Analysis
3.5.1 Oral Rabies Vaccine Market: Region Footprint
3.5.2 Oral Rabies Vaccine Market: Company Product Type Footprint
3.5.3 Oral Rabies Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Oral Rabies Vaccine Market Size by Region
4.1.1 Global Oral Rabies Vaccine Sales Quantity by Region (2018-2029)
4.1.2 Global Oral Rabies Vaccine Consumption Value by Region (2018-2029)
4.1.3 Global Oral Rabies Vaccine Average Price by Region (2018-2029)
4.2 North America Oral Rabies Vaccine Consumption Value (2018-2029)
4.3 Europe Oral Rabies Vaccine Consumption Value (2018-2029)
4.4 Asia-Pacific Oral Rabies Vaccine Consumption Value (2018-2029)
4.5 South America Oral Rabies Vaccine Consumption Value (2018-2029)
4.6 Middle East and Africa Oral Rabies Vaccine Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Oral Rabies Vaccine Sales Quantity by Type (2018-2029)
5.2 Global Oral Rabies Vaccine Consumption Value by Type (2018-2029)
5.3 Global Oral Rabies Vaccine Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Oral Rabies Vaccine Sales Quantity by Application (2018-2029)
6.2 Global Oral Rabies Vaccine Consumption Value by Application (2018-2029)
6.3 Global Oral Rabies Vaccine Average Price by Application (2018-2029)
7 North America
7.1 North America Oral Rabies Vaccine Sales Quantity by Type (2018-2029)
7.2 North America Oral Rabies Vaccine Sales Quantity by Application (2018-2029)
7.3 North America Oral Rabies Vaccine Market Size by Country
7.3.1 North America Oral Rabies Vaccine Sales Quantity by Country (2018-2029)
7.3.2 North America Oral Rabies Vaccine Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Oral Rabies Vaccine Sales Quantity by Type (2018-2029)
8.2 Europe Oral Rabies Vaccine Sales Quantity by Application (2018-2029)
8.3 Europe Oral Rabies Vaccine Market Size by Country
8.3.1 Europe Oral Rabies Vaccine Sales Quantity by Country (2018-2029)
8.3.2 Europe Oral Rabies Vaccine Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Oral Rabies Vaccine Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Oral Rabies Vaccine Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Oral Rabies Vaccine Market Size by Region
9.3.1 Asia-Pacific Oral Rabies Vaccine Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Oral Rabies Vaccine Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Oral Rabies Vaccine Sales Quantity by Type (2018-2029)
10.2 South America Oral Rabies Vaccine Sales Quantity by Application (2018-2029)
10.3 South America Oral Rabies Vaccine Market Size by Country
10.3.1 South America Oral Rabies Vaccine Sales Quantity by Country (2018-2029)
10.3.2 South America Oral Rabies Vaccine Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Oral Rabies Vaccine Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Oral Rabies Vaccine Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Oral Rabies Vaccine Market Size by Country
11.3.1 Middle East & Africa Oral Rabies Vaccine Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Oral Rabies Vaccine Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Oral Rabies Vaccine Market Drivers
12.2 Oral Rabies Vaccine Market Restraints
12.3 Oral Rabies Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Oral Rabies Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Oral Rabies Vaccine
13.3 Oral Rabies Vaccine Production Process
13.4 Oral Rabies Vaccine Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Oral Rabies Vaccine Typical Distributors
14.3 Oral Rabies Vaccine Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

List of Tables
Table 1. Global Oral Rabies Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Oral Rabies Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Boehringer Ingelheim(Merial) Basic Information, Manufacturing Base and Competitors
Table 4. Boehringer Ingelheim(Merial) Major Business
Table 5. Boehringer Ingelheim(Merial) Oral Rabies Vaccine Product and Services
Table 6. Boehringer Ingelheim(Merial) Oral Rabies Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Boehringer Ingelheim(Merial) Recent Developments/Updates
Table 8. Ceva Santé Animale(Artemis Technologies) Basic Information, Manufacturing Base and Competitors
Table 9. Ceva Santé Animale(Artemis Technologies) Major Business
Table 10. Ceva Santé Animale(Artemis Technologies) Oral Rabies Vaccine Product and Services
Table 11. Ceva Santé Animale(Artemis Technologies) Oral Rabies Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Ceva Santé Animale(Artemis Technologies) Recent Developments/Updates
Table 13. Virbac Basic Information, Manufacturing Base and Competitors
Table 14. Virbac Major Business
Table 15. Virbac Oral Rabies Vaccine Product and Services
Table 16. Virbac Oral Rabies Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Virbac Recent Developments/Updates
Table 18. Global Oral Rabies Vaccine Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 19. Global Oral Rabies Vaccine Revenue by Manufacturer (2018-2023) & (USD Million)
Table 20. Global Oral Rabies Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Market Position of Manufacturers in Oral Rabies Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 22. Head Office and Oral Rabies Vaccine Production Site of Key Manufacturer
Table 23. Oral Rabies Vaccine Market: Company Product Type Footprint
Table 24. Oral Rabies Vaccine Market: Company Product Application Footprint
Table 25. Oral Rabies Vaccine New Market Entrants and Barriers to Market Entry
Table 26. Oral Rabies Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 27. Global Oral Rabies Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 28. Global Oral Rabies Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 29. Global Oral Rabies Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 30. Global Oral Rabies Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 31. Global Oral Rabies Vaccine Average Price by Region (2018-2023) & (US$/Unit)
Table 32. Global Oral Rabies Vaccine Average Price by Region (2024-2029) & (US$/Unit)
Table 33. Global Oral Rabies Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 34. Global Oral Rabies Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 35. Global Oral Rabies Vaccine Consumption Value by Type (2018-2023) & (USD Million)
Table 36. Global Oral Rabies Vaccine Consumption Value by Type (2024-2029) & (USD Million)
Table 37. Global Oral Rabies Vaccine Average Price by Type (2018-2023) & (US$/Unit)
Table 38. Global Oral Rabies Vaccine Average Price by Type (2024-2029) & (US$/Unit)
Table 39. Global Oral Rabies Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 40. Global Oral Rabies Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 41. Global Oral Rabies Vaccine Consumption Value by Application (2018-2023) & (USD Million)
Table 42. Global Oral Rabies Vaccine Consumption Value by Application (2024-2029) & (USD Million)
Table 43. Global Oral Rabies Vaccine Average Price by Application (2018-2023) & (US$/Unit)
Table 44. Global Oral Rabies Vaccine Average Price by Application (2024-2029) & (US$/Unit)
Table 45. North America Oral Rabies Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 46. North America Oral Rabies Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 47. North America Oral Rabies Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 48. North America Oral Rabies Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 49. North America Oral Rabies Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 50. North America Oral Rabies Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 51. North America Oral Rabies Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 52. North America Oral Rabies Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 53. Europe Oral Rabies Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 54. Europe Oral Rabies Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 55. Europe Oral Rabies Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 56. Europe Oral Rabies Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 57. Europe Oral Rabies Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 58. Europe Oral Rabies Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 59. Europe Oral Rabies Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 60. Europe Oral Rabies Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 61. Asia-Pacific Oral Rabies Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 62. Asia-Pacific Oral Rabies Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 63. Asia-Pacific Oral Rabies Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 64. Asia-Pacific Oral Rabies Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 65. Asia-Pacific Oral Rabies Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 66. Asia-Pacific Oral Rabies Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 67. Asia-Pacific Oral Rabies Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 68. Asia-Pacific Oral Rabies Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 69. South America Oral Rabies Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 70. South America Oral Rabies Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 71. South America Oral Rabies Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 72. South America Oral Rabies Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 73. South America Oral Rabies Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 74. South America Oral Rabies Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 75. South America Oral Rabies Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 76. South America Oral Rabies Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 77. Middle East & Africa Oral Rabies Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 78. Middle East & Africa Oral Rabies Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 79. Middle East & Africa Oral Rabies Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 80. Middle East & Africa Oral Rabies Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 81. Middle East & Africa Oral Rabies Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 82. Middle East & Africa Oral Rabies Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 83. Middle East & Africa Oral Rabies Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 84. Middle East & Africa Oral Rabies Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 85. Oral Rabies Vaccine Raw Material
Table 86. Key Manufacturers of Oral Rabies Vaccine Raw Materials
Table 87. Oral Rabies Vaccine Typical Distributors
Table 88. Oral Rabies Vaccine Typical Customers
List of Figures
Figure 1. Oral Rabies Vaccine Picture
Figure 2. Global Oral Rabies Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Oral Rabies Vaccine Consumption Value Market Share by Type in 2022
Figure 4. Modified Live Virus Examples
Figure 5. Recombinant Vaccinia Examples
Figure 6. Recombinant Adenovirus Vaccine Examples
Figure 7. Global Oral Rabies Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Oral Rabies Vaccine Consumption Value Market Share by Application in 2022
Figure 9. Government Examples
Figure 10. Commercial Examples
Figure 11. Global Oral Rabies Vaccine Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Oral Rabies Vaccine Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Oral Rabies Vaccine Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Oral Rabies Vaccine Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Oral Rabies Vaccine Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Oral Rabies Vaccine Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Oral Rabies Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Oral Rabies Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Oral Rabies Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Oral Rabies Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Oral Rabies Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Oral Rabies Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Oral Rabies Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Oral Rabies Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Oral Rabies Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Oral Rabies Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Oral Rabies Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Oral Rabies Vaccine Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Oral Rabies Vaccine Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global Oral Rabies Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Oral Rabies Vaccine Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Oral Rabies Vaccine Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America Oral Rabies Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Oral Rabies Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Oral Rabies Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Oral Rabies Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Oral Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Oral Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Oral Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Oral Rabies Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Oral Rabies Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Oral Rabies Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Oral Rabies Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Oral Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Oral Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Oral Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Oral Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Oral Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Oral Rabies Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Oral Rabies Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Oral Rabies Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Oral Rabies Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 53. China Oral Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Oral Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Oral Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Oral Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Oral Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Oral Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Oral Rabies Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Oral Rabies Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Oral Rabies Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Oral Rabies Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Oral Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Oral Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Oral Rabies Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Oral Rabies Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Oral Rabies Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Oral Rabies Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Oral Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Oral Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Oral Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Oral Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Oral Rabies Vaccine Market Drivers
Figure 74. Oral Rabies Vaccine Market Restraints
Figure 75. Oral Rabies Vaccine Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Oral Rabies Vaccine in 2022
Figure 78. Manufacturing Process Analysis of Oral Rabies Vaccine
Figure 79. Oral Rabies Vaccine Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界のペット用狂犬病ワクチン市場2023年：企業・地域・タイプ・用途別分析
  • 世界の凍結乾燥ヒト狂犬病ワクチン市場2023年：企業・地域・タイプ・用途別分析
  • 世界のヒト狂犬病ワクチン（ベロセル）市場2023年：企業・地域・タイプ・用途別分析
  • 腸チフス経口ワクチンのグローバル市場2023：弱毒化生ワクチン、生ワクチン
  • ボルデテラ経口ワクチンのグローバル市場2023：混合ワクチン、ボルデテラワクチンのみ
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR23AG11498 )"経口狂犬病ワクチンのグローバル市場2023：改変生ウイルス、組換えワクシニア、組換えアデノウイルスワクチン" (英文：Global Oral Rabies Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。